Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson
These companies have been focusing on growing their operations, but which stock is likely to provide investors with better returns?
Mindfully Curated
These companies have been focusing on growing their operations, but which stock is likely to provide investors with better returns?
This under-the-radar stock deserves your attention.
Many cybersecurity stocks have generated meaningful returns for investors in recent years.
The streaming leader is down 80% from its peak. Here’s how it is turning around.
Bitcoin and Solana may be down in January, but both have strong catalysts in place for 2024.
It will be a challenge to find businesses that are of higher quality than Mastercard.
To say the stock has been on a bumpy ride over the years would be a huge understatement.
The conglomerate has returned nearly 20% annually since Buffett took over, but is it still a worthwhile buy today?
Tesla issued another disappointing earnings report.
Its new approach to treating cancer is more than just a nibble around the edges.
Netflix has delivered four consecutive quarters of accelerating growth. Is it time to buy the stock?
2024 could be an important year for the biotech.
Even though the stock market just hit new highs, I’m still buying.
Can the beaten-down stock turn things around?
A proposed Fiscal Commission could recommend ways to bolster Social Security. But some fear it could also push for benefit cuts.
VinFast’s Q4 and full-year deliveries are a mix of good and bad. Here’s what you need to know.
Eli Lilly is the world’s largest healthcare company by market cap, and the 10th most valuable business in the world.
The stock has rallied from its all-time low, but this business is still not generating a profit.
Meta Platforms is going all-in on Nvidia’s H100 GPUs through the end of the year.
Ford and Rivian both make EV trucks. Does Ford’s recent move with the F-150 Lightning spell bad news for Rivian’s R1T?